- Glenview Capital Management’s
13F portfolio value increased from ~$4.7B to ~$5.72B this quarter.
- They increased Corteva (CTVA)
and Universal Health Services (UHS) while reducing Tenet Healthcare (THC)
and Cigna (CI).
- The top three individual
stock stakes are Tenet Healthcare (THC), Cigna (CI), and Corteva (CTVA).
They add up to ~28% of the portfolio.
This article is part of a series that provides an ongoing
analysis of the changes made to Larry Robbins’ 13F portfolio on a quarterly
basis. It is based on Robbins’ regulatory 13F
Form filed on 5/15/2024. Please visit our Tracking
Larry Robbins’ Glenview Capital Management Portfolio article for an idea on
his investment philosophy and our previous
update for the fund’s moves during Q4 2023.
This quarter, Robbins’ 13F portfolio value increased from ~$4.7B to ~$5.72B. There are 31 positions that are significantly large. The spreadsheet below lists those larger positions individually. The top five individual stock stakes are Tenet Healthcare (THC), Cigna (CI), Corteva (CTVA), United Health Services (UHS), and Global Payments (GPN). Together they are at ~41% of the 13F assets.
The spreadsheet below highlights changes to Robbins’ 13F stock holdings in Q1 2024:
Source: John Vincent. Data constructed from Glenview Capital
Management’s 13F filings for Q4 2023 and Q1 2024.
No comments :
Post a Comment